Affiliations
AffiliationsItem in Clipboard
Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviorsMatthew M Miller et al. Breast Cancer Res Treat. 2021 Aug.
. 2021 Aug;189(1):237-246. doi: 10.1007/s10549-021-06252-1. Epub 2021 May 25. AffiliationsItem in Clipboard
AbstractPurpose: In order to facilitate targeted outreach, we sought to identify patient populations with a lower likelihood of returning for breast cancer screening after COVID-19-related imaging center closures.
Methods: Weekly total screening mammograms performed throughout 2019 (baseline year) and 2020 (COVID-19-impacted year) were compared. Demographic and clinical characteristics, including age, race, ethnicity, breast density, breast cancer history, insurance status, imaging facility type used, and need for interpreter, were compared between patients imaged from March 16 to October 31 in 2019 (baseline cohort) and 2020 (COVID-19-impacted cohort). Census data and an online map service were used to impute socioeconomic variables and calculate travel times for each patient. Logistic regression was used to identify patient characteristics associated with a lower likelihood of returning for screening after COVID-19-related closures.
Results: The year-over-year cumulative difference in screening mammogram volumes peaked in week 21, with 2962 fewer exams in the COVID-19-impacted year. By week 47, this deficit had reduced by 49.4% to 1498. A lower likelihood of returning for screening after COVID-19-related closures was independently associated with younger age (odds ratio (OR) 0.78, p < 0.001), residence in a higher poverty area (OR 0.991, p = 0.014), lack of health insurance (OR 0.65, p = 0.007), need for an interpreter (OR 0.68, p = 0.029), longer travel time (OR 0.998, p < 0.001), and utilization of mobile mammography services (OR 0.27, p < 0.001).
Conclusion: Several patient factors are associated with a lower likelihood of returning for screening mammography after COVID-19-related closures. Knowledge of these factors can guide targeted outreach to vulnerable patients to facilitate breast cancer screening.
Keywords: Breast cancer; COVID-19 pandemic; Patient travel time; Screening mammography.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statementNone of the authors has any conflict of interest or competing interests related to this study.
FiguresFig. 1
Impact of COVID-19 on mammographic…
Fig. 1
Impact of COVID-19 on mammographic breast cancer screening volumes: a Screening mammograms performed…
Fig. 1Impact of COVID-19 on mammographic breast cancer screening volumes: a Screening mammograms performed by week for 2019 (baseline year) and 2020 (COVID-19-impacted year). b Cumulative year-to-date screening mammograms performed by week for 2019 and 2020. c Cumulative difference of year-to-date screening mammograms between 2019 and 2020
Fig. 2
Impact of COVID-19 on mammographic…
Fig. 2
Impact of COVID-19 on mammographic breast cancer screening volumes by geographic region: a…
Fig. 2Impact of COVID-19 on mammographic breast cancer screening volumes by geographic region: a Number of patients screened at a University of Virginia mammography facility in 2019 by census tract. b Percent change in number of patients from a particular census tract screened at a University of Virginia facility in 2020 compared to 2019. Percent change calculated as [(# screened in 2020 − # screened in 2019)/# screened in 2019] × 100%
Similar articlesDontchos BN, Achibiri J, Mercaldo SF, Wang GX, Lamb LR, Miles RC, Narayan AK, Lehman CD. Dontchos BN, et al. AJR Am J Roentgenol. 2022 Feb;218(2):270-278. doi: 10.2214/AJR.21.26597. Epub 2021 Sep 8. AJR Am J Roentgenol. 2022. PMID: 34494449
Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O'Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli KJ, Lee JM, Lee CI. Miglioretti DL, et al. JAMA Netw Open. 2021 Mar 1;4(3):e211974. doi: 10.1001/jamanetworkopen.2021.1974. JAMA Netw Open. 2021. PMID: 33764423 Free PMC article.
Crivellaro P, Tafur M, George R, Muradali D. Crivellaro P, et al. Eur Radiol. 2022 Jan;32(1):613-620. doi: 10.1007/s00330-021-08117-z. Epub 2021 Jun 18. Eur Radiol. 2022. PMID: 34143286 Free PMC article.
Tsapatsaris A, Babagbemi K, Reichman MB. Tsapatsaris A, et al. Clin Imaging. 2022 Feb;82:224-227. doi: 10.1016/j.clinimag.2021.11.025. Epub 2021 Dec 7. Clin Imaging. 2022. PMID: 34896935 Free PMC article. Review.
Freer PE. Freer PE. Radiol Clin North Am. 2021 Jan;59(1):1-11. doi: 10.1016/j.rcl.2020.09.008. Epub 2020 Sep 22. Radiol Clin North Am. 2021. PMID: 33222992 Free PMC article. Review.
Mason H, Friedrich AK, Niakan S, Jacobbe D, Casaubon J, Pérez Coulter A. Mason H, et al. Eur J Breast Health. 2022 Sep 28;18(4):306-314. doi: 10.4274/ejbh.galenos.2022.2022-4-4. eCollection 2022 Oct. Eur J Breast Health. 2022. PMID: 36248752 Free PMC article.
Joung RH, Nelson H, Mullett TW, Kurtzman SH, Shafir S, Harris JB, Yao KA, Brajcich BC, Bilimoria KY, Cance WG. Joung RH, et al. Cancer. 2022 Jun 1;128(11):2119-2125. doi: 10.1002/cncr.34157. Epub 2022 Mar 21. Cancer. 2022. PMID: 35307815 Free PMC article.
Ng JS, Hamilton DG. Ng JS, et al. J Med Screen. 2022 Dec;29(4):209-218. doi: 10.1177/09691413221101807. Epub 2022 May 20. J Med Screen. 2022. PMID: 35593115 Free PMC article. Review.
Wang H, Yang M, Xiong W, Wang Q, Zheng B, Bai Y, Zou K, Li J, Ren J, Chen W, Zhai J, Li J. Wang H, et al. Fundam Res. 2024 Feb 8;4(3):484-494. doi: 10.1016/j.fmre.2023.12.016. eCollection 2024 May. Fundam Res. 2024. PMID: 38933198 Free PMC article. Review.
Nguyen DL, Ambinder EB, Myers KS, Oluyemi E. Nguyen DL, et al. Acad Radiol. 2022 Dec;29(12):1852-1860. doi: 10.1016/j.acra.2022.03.017. Epub 2022 Mar 25. Acad Radiol. 2022. PMID: 35562265 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3